On May 30, 2024, Merck & Co., Inc announced that it held its annual general meeting of shareholders on May 28, 2024, and declared voting results. Accordingly, a shareholder proposal regarding a government censorship transparency report submitted by National Legal and Policy Center was not approved by the Company shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.8 USD | -1.28% |
|
+0.12% | +19.08% |
27/06 | FDA Turns Away Daiichi Sankyo, Merck Lung-Cancer ADC | DJ |
27/06 | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.08% | 333B | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B | |
-3.44% | 155B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Declaration of Voting Results by Merck & Co